Invention Grant
- Patent Title: Delivery of therapeutic alkaloid compounds
-
Application No.: US17976150Application Date: 2022-10-28
-
Publication No.: US11999694B2Publication Date: 2024-06-04
- Inventor: Jacob M. Hooker , Michael S. Placzek
- Applicant: Sensorium Therapeutics, Inc.
- Applicant Address: US MA Boston
- Assignee: Sensorium Therapeutics, Inc.
- Current Assignee: Sensorium Therapeutics, Inc.
- Current Assignee Address: US MA Boston
- Agency: Foley Hoag LLP
- Agent Dana M. Gordon
- Main IPC: C07D209/12
- IPC: C07D209/12 ; C07D401/12 ; C07D405/12 ; C07D409/12 ; C07D475/04 ; C07D491/113 ; C07D491/20 ; C07D495/04 ; C07D495/10 ; C07D497/10 ; C07D498/10 ; C07D519/00 ; C07F7/18
Abstract:
Disclosed are prodrug compounds that can be converted to mesembrine under biologically relevant conditions, such as hydrolysis in vivo; and related methods of preparing and using these compounds. Stable preparations of isolated mesembrine stereoisomers are also provided.
Public/Granted literature
- US20230159455A1 DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS Public/Granted day:2023-05-25
Information query
